Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial - Reuters

1 year ago 29

Lilly cause slows Alzheimer's by 60% for mildly impaired patients successful trial Reuters
Treating Alzheimer's Very Early Offers Better Hope of Slowing Decline, Study Finds The New York Times
New Alzheimer's drugs could spell 'beginning of the end' for disease Sky News
Eli Lilly’s Alzheimer’s cause slows representation decline, survey finds NBC News
Second Alzheimer’s cause to dilatory disease’s progression whitethorn beryllium approved successful the US this year CNN
View Full Coverage connected Google News

Read Entire Article